AbbVie Inc. Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31)
AbbVie Inc. (ABBV) reported Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) of $7.00 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes
us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarnings · last filed 2014-08-07
- AbbVie Inc. participating securities, distributed and undistributed earnings (deprecated 2014-01-31) for the quarter ending 2014-06-30 was $7.00M.
- AbbVie Inc. participating securities, distributed and undistributed earnings (deprecated 2014-01-31) for the quarter ending 2014-03-31 was $4.00M.
- AbbVie Inc. participating securities, distributed and undistributed earnings (deprecated 2014-01-31) for the quarter ending 2013-12-31 was $9.00M.
- AbbVie Inc. participating securities, distributed and undistributed earnings (deprecated 2014-01-31) for the quarter ending 2013-09-30 was $6.00M.
- AbbVie Inc. participating securities, distributed and undistributed earnings (deprecated 2014-01-31) for fiscal 2013 was $26.00M.
| Period end | Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) 3 month | Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) 6 month | Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) 9 month | Participating Securities, Distributed and Undistributed Earnings (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2014-06-30 | $7.00M 10-Q · filed 2014-08-07 | $11.00M 10-Q · filed 2014-08-07 | $20.00M derived: sum of 3 quarters · filed 2014-08-07 | $26.00M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | $4.00M 10-Q · filed 2014-05-09 | $13.00M derived: sum of 2 quarters · filed 2014-05-09 | $19.00M derived: sum of 3 quarters · filed 2014-05-09 | |
| 2013-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $15.00M derived: sum of 2 quarters · filed 2014-02-21 | $26.00M 10-K · filed 2014-02-21 | |
| 2013-09-30 | $6.00M 10-Q · filed 2013-11-12 | $17.00M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |